ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,384, issued on Sept. 8, was assigned to Eidgenossische Technische Hochschule Zurich (Zurich, Switzerland).
"Method to treat disease using a nucleic acid vector encoding a highly compact multi-input logic gate" was invented by Yaakov Benenson (Binningen, Switzerland) and Bartolomeo Angelici (Basel, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are contiguous DNA sequences encoding highly compact multi-input genetic logic gates for precise in vivo cell targeting, and methods of treating disease using a combination of in vivo delivery and such contiguous DNA sequences."
The patent was filed on Oct. 10, 2019, under Applica...